Federated Hermes’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.1K Buy
463
+2
+0.4% +$393 ﹤0.01% 1614
2026
Q1
$90.3K Sell
461
-14
-3% -$2.72K ﹤0.01% 1597
2025
Q4
$82.4K Sell
475
-3
-0.6% -$546 ﹤0.01% 1593
2025
Q3
$91.1K Buy
+478
New +$84.8K ﹤0.01% 1590
2025
Q2
Sell
-488
Closed -$82.6K 2091
2025
Q1
$82.6K Sell
488
-745
-60% -$122K ﹤0.01% 1595
2024
Q4
$186K Buy
1,233
+862
+232% +$134K ﹤0.01% 1491
2024
Q3
$57.6K Sell
371
-938
-72% -$140K ﹤0.01% 1632
2024
Q2
$179K Buy
1,309
+768
+142% +$105K ﹤0.01% 1499
2024
Q1
$72K Buy
541
+123
+29% +$16K ﹤0.01% 1594
2023
Q4
$57.6K Sell
418
-1
-0.2% -$131 ﹤0.01% 1631
2023
Q3
$51.1K Buy
+419
New +$55.8K ﹤0.01% 1662
2023
Q2
Sell
-2,587
Closed -$366K 2130
2023
Q1
$366K Sell
2,587
-480
-16% -$68.7K ﹤0.01% 1475
2022
Q4
$480K Sell
3,067
-283
-8% -$40.7K ﹤0.01% 1377
2022
Q3
$411K Sell
3,350
-2,638
-44% -$347K ﹤0.01% 1385
2022
Q2
$796K Sell
5,988
-1,238
-17% -$169K ﹤0.01% 1224
2022
Q1
$989K Buy
7,226
+4,613
+177% +$643K ﹤0.01% 1256
2021
Q4
$453K Sell
2,613
-626
-19% -$95.2K ﹤0.01% 1505
2021
Q3
$471K Buy
3,239
+2,380
+277% +$348K ﹤0.01% 1514
2021
Q2
$113K Sell
859
-1,147
-57% -$150K ﹤0.01% 1770
2021
Q1
$257K Buy
2,006
+1,040
+108% +$128K ﹤0.01% 1668
2020
Q4
$115K Sell
966
-159
-14% -$19.4K ﹤0.01% 1739
2020
Q3
$129K Sell
1,125
-91
-7% -$10.8K ﹤0.01% 1701
2020
Q2
$138K Buy
1,216
+88
+8% +$9.33K ﹤0.01% 1672
2020
Q1
$91K Sell
1,128
-643
-36% -$66.6K ﹤0.01% 1660
2019
Q4
$189K Sell
1,771
-40,550
-96% -$4.23M ﹤0.01% 1612
2019
Q3
$4.53M Sell
42,321
-23,800
-36% -$2.44M 0.01% 796
2019
Q2
$6.73M Sell
66,121
-32,414
-33% -$3.11M 0.02% 699
2019
Q1
$8.86M Buy
98,535
+41
+0% +$3.55K 0.02% 610
2018
Q4
$8.2M Sell
98,494
-12,707
-11% -$1.19M 0.02% 558
2018
Q3
$12M Sell
111,201
-6,921
-6% -$759K 0.03% 508
2018
Q2
$13M Sell
118,122
-4,729
-4% -$493K 0.04% 371
2018
Q1
$12.3M Sell
122,851
-59,429
-33% -$6.09M 0.04% 369
2017
Q4
$18M Sell
182,280
-110,219
-38% -$10.4M 0.05% 278
2017
Q3
$27.4M Buy
292,499
+32,523
+13% +$3.45M 0.08% 212
2017
Q2
$28.9M Sell
259,976
-59,499
-19% -$6.29M 0.08% 211
2017
Q1
$31.4M Buy
319,475
+316,571
+10,901% +$30.2M 0.09% 199
2016
Q4
$267K Sell
2,904
-56,440
-95% -$4.86M ﹤0.01% 1457
2016
Q3
$5.02M Sell
59,344
-97,115
-62% -$8.16M 0.01% 567
2016
Q2
$12.7M Sell
156,459
-78,362
-33% -$5.97M 0.04% 376
2016
Q1
$16.8M Sell
234,821
-21,395
-8% -$1.43M 0.05% 302
2015
Q4
$18.2M Buy
256,216
+3,654
+1% +$246K 0.06% 295
2015
Q3
$15.5M Buy
252,562
+24,401
+11% +$1.71M 0.05% 333
2015
Q2
$16.5M Buy
228,161
+46,159
+25% +$3.41M 0.05% 364
2015
Q1
$14M Buy
182,002
+5,441
+3% +$390K 0.04% 386
2014
Q4
$11.8M Buy
176,561
+8,179
+5% +$516K 0.04% 412
2014
Q3
$10.2M Sell
168,382
-521
-0.3% -$32.1K 0.03% 437
2014
Q2
$9.91M Sell
168,903
-11,079
-6% -$649K 0.03% 455
2014
Q1
$10.4M Buy
179,982
+22,082
+14% +$1.18M 0.03% 453
2013
Q4
$8.45M Sell
157,900
-94,914
-38% -$5.63M 0.03% 501
2013
Q3
$15.6M Buy
252,814
+24,622
+11% +$1.47M 0.06% 274
2013
Q2
$13.8M Buy
+228,192
New +$13.6M 0.05% 274

Other funds holding DGX

Federated Hermes's DGX Position: Q2 2026 in Review

Federated Hermes increased its Quest Diagnostics (DGX) stake by 0.43% in Q2 2026, buying an estimated $393 and bringing the position to 463 shares worth $98.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1614.

Federated Hermes first reported a position in DGX in Q2 2013 and has held it in 51 quarters since. The position peaked at $31.4M in Q1 2017. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Federated Hermes held 463 shares of Quest Diagnostics worth $98.1K as of Q2 2026.
  • Federated Hermes bought 2 Quest Diagnostics shares in Q2 2026, an estimated $393.
  • Quest Diagnostics made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1614 holding.
  • Federated Hermes first reported a position in Quest Diagnostics in Q2 2013 and has held it in 51 quarters since.
  • Federated Hermes's Quest Diagnostics position peaked at $31.4M in Q1 2017.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.